FDA Clearance Tracker · K254071
p17 XR Microcatheter
Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 18, 2026
Substantially Equivalent
Time to decision
243 days
Received Dec 18, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K254071
- Device name
- p17 XR Microcatheter
- Applicant
- Wallaby Medical
- Applicant location
- Laguna Hills, CA
- Received
- Dec 18, 2025
- Decided
- Aug 18, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1250
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QJP. The earliest in FDA's data is K200206, decided Feb 27, 2020.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K254071
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Wallaby Medical
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K240917 · Decided Oct 1, 2024 · 181 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
K231056 · Decided Mar 8, 2024 · 330 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K232437 · Decided Oct 13, 2023 · 60 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.